As we all know, the PURE GBL cleaner is commonly used as the very effective cleaning agent for removing graffiti and it could also be used as the polishing detergent for car rims. It is indeed that the graffiti is still very annoying problem for houses and companies and people are powerless against graffiti sprayers. However, the high performance GBL cleaning detergent could help people easily deal with these annoying problems. By the help of GBL, people will no longer need to scrub with soap to remove these stains from walls.
Continue reading “GBL cleaning product online shop”
The launch of Qingkong Crossing Digital Industry Fund
Qingkong Crossing Digital Industry Fund Launched.
Blockchain 3.0 votes change consensus unveiled at 9.8 CIFIT
On September 9th, the 20th China International Investment and Trade Fair – 2018 blockchain technology enabling entity economic investment forum was held in Xiamen, this forum was hosted by China Investment Association Investment Advisory Committee, Tsinghua x-lab Ivy The Chain Alliance Research Institute and the Shun Tak T30 Parent Fund jointly hosted.
Chairman of the China Investment Association Investment Advisory Committee, Mr. Huiye Zhu, Secretary General of the China Electronic Chamber of Commerce Blockchain Special Committee Mr. Li Yinke, the president of Tsinghua x-lab lvy Chain Research Institute, Mr. Zhong Hong, Partner of the Crossing Fund, Mr. Terry Lehman and Mr. Danny Wong, Co-founders of Medivh Medical Group, Mr. Chen Jianren, Chairman of the Board of Directors of Xiaobawang Group, Mr. Yang Yun, Chairman of Board of Directors of Hong Kong Dachang Financial Technology Group, Jinhaohao Technology Holdings Mr. Jin Qiu Bing, co-founder of the group, Mr. Li Shuai, CEO of Core Cartoon Technology, and Mr. Li Hongkun, President of Diplo Continental Technology, attended the forum,the scale of this year’s Xiamen meeting is huge. More than 1,000 industrial and commercial groups, more than 5,000 companies and more than 120,000 merchants from more than 110 countries and regions gathered in Xiamen. This forum has become a highlight of this year’s Xiamen Fair. The “Qingdao Crossing Digital Industry Fund and Blockchain 3.0 Energizing Entity Economy Baicheng Baihui Project” jointly initiated by Tsinghua x-lab Qingteng Chain Research Institute, Qingkong Crossing Fund and Shunde Fund, officially launched, the future It will cooperate with 100 cities and 100 industry chambers of commerce to develop blockchain 3.0 to enable the real economy lecture hall, and find successful cases of blockchain technology application in the industry.
The forum also carried out the ceremony of “Strategic Cooperation Signing of Block Chain 3.0 vote change Laboratory” and the awarding ceremony of “Top 10 Innovative Enterprises in Block Chain Energizing Entity Economy”. The award-winning enterprises included Xiao bawang Ruyi Culture Technology Co., Ltd. (BWTT), Hong Kong Medici Medical Holding Group (MCHK), Hong Kong Dachang Financial Technology Co., Ltd. (BMY), Jinhaohao Technology Holdings (DJMT), Core Cartoon Technology (SWWT), Hong Kong Zangjintang Biotechnology ( TOT) Tiebao Continental Technology (TBB), Property Chain Technology (TCT), Shunde Parent Fund (T30), and Good Skin Biotechnology Co., Ltd. (DST).
In the speech, the Chairman of the China Investment Association’s Investment Advisory Committee, Mr. Zhu Huizhen, said that the blockchain technology itself can promote the development of the real economy. We support new technologies to bring new kinetic energy to the economy, and we hope that more entities can Participate in the practice of this blockchain 3.0 ticket reform, and make more successful cases of blockchain empowerment of the real economy.
Li Yinke, secretary general of the China Electronics Chamber of Commerce Blockchain Committee of the Ministry of Industry and Information Technology, said in his speech that the blockchain as a bottom layer technology has already made successful industrial applications in certain areas of financial technology. Core cartoon is a good example. Hope In the future, relying on the power of the Chamber of Commerce to promote more blockchain technology companies to empower the real economy.
In the theme sharing, the president of Qinghua x-lab, has proposed a blockchain 3.0 to empower the real economy, which has become a new consensus in China’s blockchain industry. Blockchain 3.0 represents the IoT-based blockchain 3.0 technology that truly links the digital economy to the real economy to form a complete blockchain technology, business and financial services ecosystem for the service industry.
The blockchain 3.0 vote change laboratory is an innovative experimental platform that promotes the blockchain 3.0 to empower the real economy. It will integrate experts in seven fields of politics, production, learning, research, investment, innovation and media to form a national ministry. The local government and industry think tanks aim to promote the transformation and upgrading of China’s current real economy, and jointly promote the research and implementation plan of the blockchain 3.0 industry vote change theory and the implementation of the blockchain industry service organization. The real economy enterprises are fully docked, and a complete vote change plan will be formed before the end of 2018, and the first batch of vote change pilot zones will be built in the country with various industry associations.
Qingkong Daokou Digital Industry Fund & Blockchain Empowerment Entity Economy Baicheng Baihui Launched.
The president of Shun Tak T30, the co-founder of the vote change lab, Hu Jiesen, made a wonderful topic sharing in the forum. He said that the essence of blockchain technology is to solve the problem of trust and consensus.
“Qingkong Daokou Digital Industry Fund”, relying on the technology and financial resources of Tsinghua Holdings and Tsinghua Wudaokou Finance College, will focus on using the power of technology and capital to help “blockchain vote change laboratory” and establish blockchain empowerment The real economy innovation ecology. The ticket-changing public chain “chain ticket” project currently being hatched is supported by the blockchain 3.0 underlying public chain technology, which will serve the assets of the entity, and relieve the inventory backlog and financing difficulties in the form of digital tickets. The problems faced by the entity enterprises, the current property chain ticket project has been applied in the medical and insurance industry. In the 2018, when the real economy encountered major challenges, the “blockchain 3.0 vote change laboratory” is incubating a batch of industry application success stories. And will rely on the strength of domestic industry associations and local governments to jointly empower the real economy.
vote change lab launching ceremony
Group photo of some guests at the meeting
For more information, please visit http://www.medisun.hk/
Medisun launched the “Hong Kong Regenerative Medisun Association”
Medisun launched the “Hong Kong Regenerative Medisun Association”
On May 28, 2018, the Hong Kong Regenerative Medisun Association, which was initiated by representatives from the Hong Kong Regenerative Medisun Industry and academic circles, was formally established under the auspices of the Medisun Medical Group.
Hong Kong Regenerative Medisun Association goals
The Hong Kong Regenerative Medisun Association was founded by experts, scholars, industry representatives and people of insight in the field of regenerative Medisun in Hong Kong and around the world. The purpose of the association is to establish a consensus platform for the regenerative Medisun industry in Hong Kong, promote the development of the regenerative Medisun industry, encourage and promote international cooperation, and propose to the Hong Kong SAR government the recommendations of the regenerative Medisun industry on industry regulations and actively influence industry rules. The establishment and improvement of the company provides effective technical and management advice to the Hong Kong government, Hong Kong public health agencies and companies in the industry.
The first meeting of the Hong Kong Regenerative Medisun Association (May 28, 2018)
On the afternoon of May 28, representatives from Hong Kong’s medical health, regenerative Medisun and biotechnology fields, doctors, pharmacists, chemists and university researchers gathered to discuss and elect the first council of the Hong Kong Regenerative Medisun Association.They read the charter of the association and clarify the duties of the board. At the same time, they have had a heated discussion on the regulatory documents issued by the Hong Kong SAR Government on Advanced Therapy Products. They agreed to regulate the direction of document guidance and proposed a number of issues that need to be clarified, including:
1. Professional qualifications required by the licensee of the Regenerative Medisun and Stem Cell Research and Development Organization;
2. Advanced Therapy Products is regulated by the Pharmacy and Poisons Ordinance (Cap. 138). However, since the production process and user definition of cellular products and pharmaceutical products are different, they should be clarified accordingly;
3. With reference to the requirements of the international GMP/PICS standard, which standard should be achieved in the cell laboratory qualification of existing regenerative Medisun institutions;
4. After the specific regulation is in force, whether there should be a transition period, so that the industry has time to adjust and cooperate;
5. Submit the Advanced Therapy Products comments and submit them to the Hong Kong Department of Health.
Member of the First Council of the Hong Kong Regenerative Medisun Association
Position |
Name |
Qualifications |
Chairman |
Danny Wong Mr. Wang Xiaofeng |
Founder and Chairman of Medisun Medical Group, years of investment experience in the field of regenerative Medisun, understanding the development and trends of the biotechnology industry |
Vice President |
Joseph Wang Dr. Wang Qiyuan |
Registered as a doctor, founder of the Hong Kong Stem Cell Center, enriching the clinical experience of regenerative Medisun |
Vice President |
David Leung Mr. Liang Yaoming |
Registered pharmacist, familiar with pharmaceutical regulations and GMP requirements |
Vice Chairman |
Gregory Cheng Professor Zheng Yanming |
Hematology expert, Professor of the University of Macau Health Sciences |
Director | Treasurer |
Kenneth Lee Dr. Li Zhisheng |
Registered as a doctor, B Q Anti-aging Center Consultant |
Director |
Philip Choy Dr. Cai Shaolong |
Ph.D. in Natural Medisun, Madison Biomedical Director |
Director |
Daniel Tam Dr. Tan Yizhu |
Registered as a medical laboratory technologist, director of the Trans-Olympic Blood Bank Laboratory, focusing on cell culture technology for many years |
Director |
Vivien Leung Ms. Liang Yiqun |
Registered as a medical laboratory technologist, manager of the Trans-Olympic Blood Bank Laboratory, familiar with quality management |
Director |
Chris Wong Dr. Huang Libao |
Registered as a medical laboratory technologist, director of HKMDPC, molecular biodiagnostic expert |
Secretary |
Sidney Tam Dr. Tan Guozhen |
Chief Executive Officer, Life Clinic, Health Management Consultant |
Secretary |
Allen Chan Mr. Chen Yuxin |
Registered as a medical laboratory technologist, familiar with quality management |
The first meeting of the Hong Kong Regenerative Medisun Association (May 28, 2018)
Hong Kong Regenerative Medisun Association’s recent work plan
Next, the Hong Kong Regenerative Medisun Association will issue letters to the organizations including the Hong Kong Department of Health, the Hong Kong Stock Exchange, the Hong Kong University Biomedical Science, Life Sciences, and the Global Regenerative Medisun Alliance (ARM). include:
1. Announced the official establishment of the Hong Kong Regenerative Medisun Association
2. Announce the initial membership list of the Hong Kong Regenerative Medisun Council, association charter, association vision and goals
3. Call for the support and participation of experts, scholars and industry representatives from Hong Kong and around the world
4. Propose to the Hong Kong Government to clarify regulatory regulations on Advanced Medisun and Advanced Therapy Products
Special thanks
Thank you for taking the time to attend the representatives of the institutions, including:
Medisun Medical Group | Medisun Reproductive Medisun Center |
Hong Kong Life Science and Technology Group Co., Ltd. |
Standard Pathology Laboratory Co., Ltd. |
BIH |
Living Tissues company limited |
BIB Health Care Centre |
Hongxin Medical Center |
Austa beauty |
Hong Kong International Regenerative Medisun Centre |
HKMPDC |
Huixin Technology |
Guangzhou Biological Institute |
Trans-along cord blood bank |
Hong Kong Stem Cell Center |
Life Length |
Biocell |
Cordlife |
For more information, please visit http://www.medisun.hk/
Medisun launched the “Hong Kong Regenerative Medisun Association”
Medisun launched the “Hong Kong Regenerative Medisun Association”
On May 28, 2018, the Hong Kong Regenerative Medisun Association, which was initiated by representatives from the Hong Kong Regenerative Medisun Industry and academic circles, was formally established under the auspices of the Medisun Medical Group.
Hong Kong Regenerative Medisun Association goals
The Hong Kong Regenerative Medisun Association was founded by experts, scholars, industry representatives and people of insight in the field of regenerative Medisun in Hong Kong and around the world. The purpose of the association is to establish a consensus platform for the regenerative Medisun industry in Hong Kong, promote the development of the regenerative Medisun industry, encourage and promote international cooperation, and propose to the Hong Kong SAR government the recommendations of the regenerative Medisun industry on industry regulations and actively influence industry rules. The establishment and improvement of the company provides effective technical and management advice to the Hong Kong government, Hong Kong public health agencies and companies in the industry.
The first meeting of the Hong Kong Regenerative Medisun Association (May 28, 2018)
On the afternoon of May 28, representatives from Hong Kong’s medical health, regenerative Medisun and biotechnology fields, doctors, pharmacists, chemists and university researchers gathered to discuss and elect the first council of the Hong Kong Regenerative Medisun Association.They read the charter of the association and clarify the duties of the board. At the same time, they have had a heated discussion on the regulatory documents issued by the Hong Kong SAR Government on Advanced Therapy Products. They agreed to regulate the direction of document guidance and proposed a number of issues that need to be clarified, including:
1. Professional qualifications required by the licensee of the Regenerative Medisun and Stem Cell Research and Development Organization;
2. Advanced Therapy Products is regulated by the Pharmacy and Poisons Ordinance (Cap. 138). However, since the production process and user definition of cellular products and pharmaceutical products are different, they should be clarified accordingly;
3. With reference to the requirements of the international GMP/PICS standard, which standard should be achieved in the cell laboratory qualification of existing regenerative Medisun institutions;
4. After the specific regulation is in force, whether there should be a transition period, so that the industry has time to adjust and cooperate;
5. Submit the Advanced Therapy Products comments and submit them to the Hong Kong Department of Health.
Member of the First Council of the Hong Kong Regenerative Medisun Association
Position |
Name |
Qualifications |
Chairman |
Danny Wong Mr. Wang Xiaofeng |
Founder and Chairman of Medisun Medical Group, years of investment experience in the field of regenerative Medisun, understanding the development and trends of the biotechnology industry |
Vice President |
Joseph Wang Dr. Wang Qiyuan |
Registered as a doctor, founder of the Hong Kong Stem Cell Center, enriching the clinical experience of regenerative Medisun |
Vice President |
David Leung Mr. Liang Yaoming |
Registered pharmacist, familiar with pharmaceutical regulations and GMP requirements |
Vice Chairman |
Gregory Cheng Professor Zheng Yanming |
Hematology expert, Professor of the University of Macau Health Sciences |
Director | Treasurer |
Kenneth Lee Dr. Li Zhisheng |
Registered as a doctor, B Q Anti-aging Center Consultant |
Director |
Philip Choy Dr. Cai Shaolong |
Ph.D. in Natural Medisun, Madison Biomedical Director |
Director |
Daniel Tam Dr. Tan Yizhu |
Registered as a medical laboratory technologist, director of the Trans-Olympic Blood Bank Laboratory, focusing on cell culture technology for many years |
Director |
Vivien Leung Ms. Liang Yiqun |
Registered as a medical laboratory technologist, manager of the Trans-Olympic Blood Bank Laboratory, familiar with quality management |
Director |
Chris Wong Dr. Huang Libao |
Registered as a medical laboratory technologist, director of HKMDPC, molecular biodiagnostic expert |
Secretary |
Sidney Tam Dr. Tan Guozhen |
Chief Executive Officer, Life Clinic, Health Management Consultant |
Secretary |
Allen Chan Mr. Chen Yuxin |
Registered as a medical laboratory technologist, familiar with quality management |
The first meeting of the Hong Kong Regenerative Medisun Association (May 28, 2018)
Hong Kong Regenerative Medisun Association’s recent work plan
Next, the Hong Kong Regenerative Medisun Association will issue letters to the organizations including the Hong Kong Department of Health, the Hong Kong Stock Exchange, the Hong Kong University Biomedical Science, Life Sciences, and the Global Regenerative Medisun Alliance (ARM). include:
1. Announced the official establishment of the Hong Kong Regenerative Medisun Association
2. Announce the initial membership list of the Hong Kong Regenerative Medisun Council, association charter, association vision and goals
3. Call for the support and participation of experts, scholars and industry representatives from Hong Kong and around the world
4. Propose to the Hong Kong Government to clarify regulatory regulations on Advanced Medisun and Advanced Therapy Products
Special thanks
Thank you for taking the time to attend the representatives of the institutions, including:
Medisun Medical Group | Medisun Reproductive Medisun Center |
Hong Kong Life Science and Technology Group Co., Ltd. |
Standard Pathology Laboratory Co., Ltd. |
BIH |
Living Tissues company limited |
BIB Health Care Centre |
Hongxin Medical Center |
Austa beauty |
Hong Kong International Regenerative Medisun Centre |
HKMPDC |
Huixin Technology |
Guangzhou Biological Institute |
Trans-along cord blood bank |
Hong Kong Stem Cell Center |
Life Length |
Biocell |
Cordlife |
For more information, please visit http://www.medisun.hk/